Literature DB >> 16157815

Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus.

Michael Colucciello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16157815     DOI： 10.1001/archopht.123.9.1273

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  19 in total

1.  Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.

Authors:  Rikje Ruiter; Loes E Visser; Myrthe P P van Herk-Sukel; Petronella H Geelhoed-Duijvestijn; Sandra de Bie; Sabine M J M Straus; Peter G M Mol; Silvana A Romio; Ron M C Herings; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

Review 2.  New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.

Authors:  Mercy Saw; Vincent W Wong; I-Van Ho; Gerald Liew
Journal:  Eye (Lond)       Date:  2019-06-21       Impact factor: 3.775

3.  Rosiglitazone (Avandia) and macular edema.

Authors:  Claire Kendall; Eric Wooltorton
Journal:  CMAJ       Date:  2006-02-08       Impact factor: 8.262

4.  Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.

Authors:  Patrizio Tatti; Franco Arrigoni; Adriano Longobardi; Flavia Costanza; Patrizia Di Blasi; Domenico Merante
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

5.  The use of optical coherence tomography to determine the effect of thiazolidinediones on retinal thickness in patients with type 2 diabetes.

Authors:  Aaron K Tarbett; Ronald C VanRoekel; Robin S Howard; Robert A Vigersky
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

6.  Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.

Authors:  Emily W Gower; James F Lovato; Walter T Ambrosius; Emily Y Chew; Ronald P Danis; Matthew D Davis; David C Goff; Craig M Greven
Journal:  Am J Ophthalmol       Date:  2017-12-22       Impact factor: 5.258

7.  Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.

Authors:  Walter T Ambrosius; Ronald P Danis; David C Goff; Craig M Greven; Hertzel C Gerstein; Robert M Cohen; Matthew C Riddle; Michael E Miller; John B Buse; Denise E Bonds; Kevin A Peterson; Yves D Rosenberg; Letitia H Perdue; Barbara A Esser; Lea A Seaquist; James V Felicetta; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2010-03

8.  Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.

Authors:  Saumya Reddy Kankanala; Rafay Syed; Quan Gong; Boxu Ren; Xiaoquan Rao; Jixin Zhong
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 9.  Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.

Authors:  Janaka Karalliedde; Robin E Buckingham
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 10.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.